Evidence map›Paper›PMID 33560466›Full record

ArticleAnnals of biomedical engineering2021

Effect of 3D Printing Temperature on Bioactivity of Bone Morphogenetic Protein-2 Released from Polymeric Constructs.

Gerry L Koons, Panayiotis D Kontoyiannis, Mani Diba, Letitia K Chim, David W Scott, Antonios G Mikos

Open access · greenAbstract read
In one paragraph

Article in Annals of biomedical engineering, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.8field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Application of BMP in Bone Tissue Engineering.Frontiers in bioengineering and biotechnology · 2022
    Review
  9. Advances in 3D Printing for Tissue Engineering.Materials (Basel, Switzerland) · 2021
    Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Gerry L KoonsDepartment of Bioengineering, Rice University, Houston, TX, USA.
Panayiotis D KontoyiannisDepartment of Biochemistry and Cell Biology, Rice University, Houston, TX, USA.
Mani DibaDepartment of Bioengineering, Rice University, Houston, TX, USA.
Letitia K ChimDepartment of Bioengineering, Rice University, Houston, TX, USA.
David W ScottDepartment of Statistics, Rice University, Houston, TX, USA.
Antonios G MikosDepartment of Bioengineering, Rice University, Houston, TX, USA. mikos@rice.edu.
Rice University · USBaylor College of Medicine · US

Funding

Training and Dissemination CoreP41EB023833 · NIBIB · UNIV OF MARYLAND, COLLEGE PARK · PI FISHER, JOHN P, MIKOS, ANTONIOS G. · 2017 to 2021
$6.2M
Nederlandse Organisatie voor Wetenschappelijk Onderzoek 019.182EN.004NIBIB NIH HHS P41 EB023833Robert and Janice McNair Foundation MD/PhD Student Scholar Program
6 · The paper itself

Abstract

Growth factors such as bone morphogenetic protein-2 (BMP-2) are potent tools for tissue engineering. Three-dimensional (3D) printing offers a potential strategy for delivery of BMP-2 from polymeric constructs; however, these biomolecules are sensitive to inactivation by the elevated temperatures commonly employed during extrusion-based 3D printing. Therefore, we aimed to correlate printing temperature to the bioactivity of BMP-2 released from 3D printed constructs composed of a model polymer, poly(propylene fumarate). Following encapsulation of BMP-2 in poly(DL-lactic-co-glycolic acid) particles, growth factor-loaded fibers were fabricated at three different printing temperatures. Resulting constructs underwent 28 days of aqueous degradation for collection of released BMP-2. Supernatants were then assayed for the presence of bioactive BMP-2 using a cellular assay for alkaline phosphatase activity. Cumulative release profiles indicated that BMP-2 released from constructs that were 3D printed at physiologic and intermediate temperatures exhibited comparable total amounts of bioactive BMP-2 release as those encapsulated in non-printed particulate delivery vehicles. Meanwhile, the elevated printing temperature of 90 °C resulted in a decreased amount of total bioactive BMP-2 release from the fibers. These findings elucidate the effects of elevated printing temperatures on BMP-2 bioactivity during extrusion-based 3D printing, and enlighten polymeric material selection for 3D printing with growth factors.

Indexed as

Printing, Three-DimensionalTissue ScaffoldsAnimalsBone Morphogenetic Protein 2Cell LineFumaratesMicePolylactic Acid-Polyglycolic Acid CopolymerPolypropylenesTemperatureBMP2 protein, humanBone Morphogenetic Protein 2FumaratesPolylactic Acid-Polyglycolic Acid Copolymerpoly(propylene fumarate)Polypropylenes3D printingBiomaterialsGrowth factorProtein deliveryTissue engineering

Identifiers

PMID33560466
PMCPMC8349935
OpenAlexW3129029517

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.